Not wanting to take any chances, drug makers pulled kids' cold medicines off the market less than two weeks after the government warned of potential health risks to infants.Products aimed at children under the age of two are being removed from store shelves due to "rare instantances of misuse" that could lead to accidental overdose, a trade group that represents over-the-counter drug makers said.
Cold medicines being withdrawn include: Johnson & Johnson Pediacare Infant Drops and Tylenol Concentrated Infants Drops, Wyeth's Dimetapp Decongestant Infant Drops, Novartis' Triaminic Infant & Toddler Thin Strips and Prestige Brands Holdings' Little Colds Decongestant Plus Cough.
CVS Caremark Corp. said Thursday morning it would remove the affected products as well as CVS-brand equivalents from store shelves.
Late last month the Food and Drug Administration tentatively recommended adding the words "do not use in children under two years" to product labeling. Current labeling directs parents to consult a doctor before administering the drugs to infants and toddlers. Government scientists also said there is little evidence that cold medicines actually work in younger children.
No comments:
Post a Comment